Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism
NCT: NCT07770451 · NOT_YET_RECRUITING
Brief Summary
Despite decades of research, no definitive, effective biological treatments exist for core symptoms of Autism Spectrum Disorder (ASD). Emerging evidence suggests that conventional Transcranial Magnetic Stimulation (TMS) targeting the dorsolateral prefrontal cortex or posterior superior temporal sulcus may reduce repetitive behaviors, but its efficacy on social communication remains inconsistent. Deep Transcranial Magnetic Stimulation (dTMS) allows for the stimulation of deeper brain structures. Deep social brain networks, such as the medial prefrontal cortex (mPFC), play a critical role in social cognition and mentalizing processes. Targeting the mPFC with dTMS holds potential for improving core impairments in social cognition among individuals with ASD. This pilot study aims to evaluate the efficacy of dTMS on social cognition, mPFC-related functional connectivity, and clinical symptoms (autism severity, stereotyped behaviors, sensory symptoms, and emotion regulation).
Frequently Asked Questions
What is Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism?
Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism is a clinical trial registered under NCT07770451. Current status: NOT_YET_RECRUITING.
What is the status of NCT07770451?
The current status of NCT07770451 (Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism) is: NOT_YET_RECRUITING.
When did Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism start?
Medial Prefrontal Cortex Brain Magnetic Stimulation in Autism started on 2026-12-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.